- Molecular NameDimercaprol
- Synonym2,3-Dimercapro; 2,3-Dimercaptopropanol; BAL; British Anti-Lewisite
- Weight124.228
- Drugbank_IDN/A
- ACS_NO59-52-9
- Show 3D model
- LogP (experiment)0.2
- LogP (predicted, AB/LogP v2.0)0.6
- pka8.6
- LogD (pH=7, predicted)0.58
- Solubility (experiment)86.9 mg/ml
- LogS (predicted, ACD/Labs)(ph=7)-0.79
- LogSw (predicted, AB/LogsW2.0)28.62
- Sw (mg/ml) (predicted, ACD/Labs)19.76
- No.of HBond Donors1
- No.of HBond Acceptors1
- No.of Rotatable Bonds2
- TPSA97.83
- StatusN/A
- AdministrationN/A
- PharmacologyIt is used medically in treatment of arsenic, mercury, gold and lead, and other toxic metal poisoning.[4] In addition, it has in the past been used for the treatment of Wilson's disease, a genetic disorder in which the body tends to retain copper.
- Absorption_valueN/A
- Absorption (description)N/A
- Caco_2N/A
- Bioavailability0.0
- Protein bindingN/A
- Volume of distribution (VD)N/A
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmN/A
- Half lifeN/A
- ExcretionN/A
- Urinary ExcretionN/A
- CleranceN/A
- ToxicityN/A
- LD50 (rat)LD50=0.85 (intraperitoneal)
- LD50 (mouse)LD50=1.5 (intraperitoneal)